Northeast, Texas 75214
214-827-3610 http://www.texasneurology.com bspears@texasneurology.com
Welcome to Texas Neurology
Mission statement: "To serve our patients, physicians, colleagues and students by providing the highest quality of neurological care, consultative services and educational opportunities."
Texas Neurology has a long, rich tradition of excellence in clinical research. We are staffed with a team of physicians with over 40 years of combined experience in pharmaceutical research who are committed to advancing medical science through research.
Texas Neurology has developed the following specialty centers: ALS Center, Clinical Research Department, Electrodiagnostic Clinic, Epilepsy Center, Fibromyalgia Center, Headache Institute, Imaging Center, Infusion Clinic, Multiple Sclerosis Center, and Sleep Disorders Center. These centers offer patients a participatory role in developing new medicines and treatments through ongoing research programs.
The investigators at Texas Neurology have experience conducting clinical trials in the following areas:
- Alzheimer's Disease
- Epilepsy/Seizure
- Migraine/Headache
- Parkinson's disease
- Multiple Sclerosis
- Amyotrophic Lateral Sclerosis
- Stroke and Cerebrovascular Disease
We are constantly striving to expand our areas of neurological research so that we may offer our patients the most advanced treatment available.
Our physician investigators are:
- Gary Tunell, MD
- Steven Herzog, MD
- Alan W. Martin, MD
- N. Bruce Jenevein, MD
- J. Theodore Phillips, MD, PhD
- Daragh Heitzman, MD
- Waleed H. El-Feky, MD
- C. Fish Greenfield, MD
A dedicated team of clinical research staff are available to manage trials from Phase I to Phase IV.
- Lori White, RN, MS, CRNI - Clinical Director with over thirty years of clinical experience
- Brent Spears, BS, CCRC - Clinical Research Manager with over six years of clinical research experience
- Janey Phillips, BS - Clinical Research Coordinator with over fourteen years of clinical research experience
- Christi Kelly, MS, CCRP - Clinical Research Coordinator with over nine years of clinical research experience
- LuAnn Tunell, BS - Clinical Research Coordinator with over two years of clinical research experience
- Shari Hand, BA, CCRC - Clinical Research Consultant with over seven years of clinical research experience
- Michelle Washington, NR-CMA - Clinical Research Assistant
Texas Neurology has an extensive patient population with well over 10,000 in a combined patient database. Approximately 75% of our patients are between the ages of 20' 60. These patients can be selected by diagnosis when required. Currently we have approximately 2600 Migraine patients, 2000 MS patients, 1400 Parkinson's patients, and more than 1000 Alzheimer's patients.
Neurology
The following equipment and services are available on-site at Texas Neurology to help facilitate the conduct of clinical research:
- Eight board-certified neurologists
- Four licensed physician assistants and three licensed nurse practitioners
- Five dedicated infusion nurses
- CLIA-certified laboratory
- Monitored -20° freezer and -80° freezer
- Liquid nitrogen storage
- Biohazard Hood
- IATA trained staff
- ECG
- DEXA scan
- Sleep lab/PSGs
- EEG
- EMG
- Magnetic Resonance Imaging - 3.0T and 1.5T
- Room temperature and refrigerated storage areas for investigational product which are secure and monitored
- Dedicated areas for research monitors
Brent Spears, BS, CCRC
Clinical Research Manager
Texas Neurology, PA
6301 Gaston Avenue, West Tower
Clinical Research
Dallas, TX 75214
USA
214-827-3610 x 228
214-279-0346 (fax)
bspears@texasneurology.com
www.texasneurology.com
- Alzheimer's Research Study
- Clinical Research Study in Early Parkinson's Disease
- Clinical Trial of Ceftriaxone in Subjects with Amyotrophic Lateral Sclerosis
- Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs
- Efficacy and Safety of Eslicarbazepine Acetate as adjunctive Therapy for refractory partial seizures in a double blind, randomized, placebo-controlled, parallel-group multicenter clinical trial